Financial Insights’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,359
Closed -$302K 131
2024
Q3
$302K Sell
3,359
-2,405
-42% -$202K 0.1% 112
2024
Q2
$454K Sell
5,764
-2,059
-26% -$169K 0.13% 104
2024
Q1
$682K Sell
7,823
-1,448
-16% -$124K 0.19% 85
2023
Q4
$764K Buy
9,271
+252
+3% +$19.2K 0.24% 76
2023
Q3
$636K Buy
9,019
+1,687
+23% +$141K 0.23% 78
2023
Q2
$646K Buy
7,332
+2,238
+44% +$193K 0.24% 79
2023
Q1
$411K Buy
+5,094
New +$415K 0.17% 106
2021
Q3
Sell
-412
Closed -$511K 167
2021
Q2
$511K Buy
+412
New +$51.7K 0.04% 158

Other funds holding MDT

Financial Insights's MDT Position: Q4 2024 in Review

Financial Insights sold out of Medtronic (MDT) in Q4 2024, closing a stake of 3,359 shares — an estimated $302K sold.

Financial Insights first reported a position in MDT in Q2 2021 and held it in 8 quarters. The position peaked at $764K in Q4 2023. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Financial Insights reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Financial Insights sold 3,359 Medtronic shares in Q4 2024, an estimated $302K.
  • Financial Insights first reported a position in Medtronic in Q2 2021 and held it in 8 quarters.
  • Financial Insights's Medtronic position peaked at $764K in Q4 2023.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Financial Insights's 13F filing for Q4 2024, filed 5 Mar 2025.